Claris Lifesciences has received an Abbreviated New Drug Application (ANDA) approval for Metoprolol Tartrate Injection; having strength of 1mg / ml in 5 ml glass vials; in the United States of America (US). Metoprolol Tartrate Injection is used to treat angina (chest pain) and hypertension (high blood pressure). It is also used to treat or prevent heart attack.
According to the American Heart Association, an estimated 1.4 million people annually will suffer a heart attack or AMI. IMS data indicates 2009 sales of Metoprolol at approximately $13 million.
Claris is also one of the few injectables companies in India to have its own front end in the US, the company markets its products through its wholly owned subsidiary Claris Lifesciences Inc. The company now has 10 ANDAs approved in its name across 6 molecules. The company has a total filing of 32 ANDAs across 21 molecules.
| Company Name | CMP |
|---|---|
| Redington | 280.90 |
| Amrapali Industries | 42.31 |
| Adani Enterprises | 3037.90 |
| Rashi Peripheral | 752.80 |
| PDS | 338.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: